How scientists redesigned an effective cancer therapy to make it safer
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...
Update on regulatory review of lecanemab for treatment of early Alzheimer's disease in the European Union
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee ...
Imaging research on monoclonal antibodies sheds light on protein dynamics for biopharmaceutical development
Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...
Business Wire2d
Ypsilon Receives $2.7 Million Non-Dilutive Grant to Advance Next-Generation TCRm Antibodies
Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...
Future Market Insights2d
Global Antibody Discovery Market Valuation Set to Total USD 21.8 Billion by 2034, Spurred by Escalating Demand for Targeted Therapies | FMI
Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...
Manas AI Launches to Transform Discovery of Novel Cancer Medicines
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...
Hosted on MSN6d
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...